Hospital admissions and mortality in AIDS patients in the HAART era.: Where are we heading?

被引:7
|
作者
Iribarren, JA
González-García, J
机构
[1] Hosp Donostia, Unidad Enfermedades Infecc, E-20080 San Sebastian, Spain
[2] Hosp La Paz, Med Interna Serv, Unidad VIH, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2004年 / 22卷 / 03期
关键词
D O I
10.1157/13058018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [1] Hospital admissions for HIV-infected patients in the era of HAART
    Manavi, K.
    HIV MEDICINE, 2010, 11 : 62 - 62
  • [2] Admission to hospital in the HAART era.: The EuroSIDA study
    Friis-Moller, N
    Kirk, O
    Mocroft, A
    Bruun, JN
    Johnson, A
    Colebunders, R
    Proenca, R
    Gonzalés-Lahoz, J
    Monforte, AD
    Lundgren, JD
    AIDS, 2000, 14 : S135 - S135
  • [3] Hospital concessions in Chile: where we are and where we are heading
    Bachelet, Vivienne C.
    MEDWAVE, 2014, 14 (10): : e6039
  • [4] CMV retinitis is a risk factor for mortality in patients with AIDS in the era of HAART
    Holbrook, J
    Jabs, DA
    Van Natta, M
    Clark, R
    Jacobson, MA
    Kempen, JH
    Murphy, RL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U412 - U412
  • [5] Neurologic complications of HIV in the HAART era: where are we?
    Gomes da Silva, Monica M.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (04): : 373 - 378
  • [6] Mortality in the HAART era at an urban teaching hospital
    Toby, M.
    Conway, K.
    Lucas, S.
    Larbalestier, N.
    Kulasegaram, R.
    HIV MEDICINE, 2012, 13 : 55 - 55
  • [7] Characterization of avoidable hospital admissions in patients with lung cancer in the immunotherapy and targeted therapy era.
    Lander, Eric Michael
    Huang, Li-Ching
    Cass, Amanda
    Skotte, Emily A.
    Whisenant, Jennifer G.
    Iams, Wade Thomas
    Lovly, Christine M.
    Osterman, Travis John
    Lewis, Jennifer A.
    York, Sally J.
    Shyr, Yu
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Changes in the spectrum of morbidity and mortality in hospital admissions of HIV infected patients during the HAART
    Hortelano, CME
    Rincón, JMR
    Rodero, FG
    Canuto, MM
    Aguado, IH
    Santaleocadia, CB
    Urrea, SP
    Martín-Hidalgo, A
    MEDICINA CLINICA, 2004, 122 (01): : 1 - 5
  • [9] Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium
    Noy, Ariela
    Lensing, Shelly Y.
    Moore, Page C.
    Gupta, Neel
    Aboulafia, David
    Ambinder, Richard
    Baiocchi, Robert
    Dezube, Bruce J.
    Henry, David
    Kaplan, Lawrence
    Levine, Alexandra M.
    Mitsuyasu, Ronald
    Ratner, Lee
    Reid, Erin
    Remick, Scot
    Sparano, Joseph
    Tzachanis, Dimitrios
    Wachsman, William
    Chadburn, Amy
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1731 - 1734
  • [10] Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
    Mereiter, Stefan
    Balmana, Meritxell
    Campos, Diana
    Gomes, Joana
    Reis, Celso A.
    CANCER CELL, 2019, 36 (01) : 6 - 16